REQUEST A DEMO
Total
USD $0.00
Search more companies

Disto Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Disto Pharmaceuticals Private Limited Profile Updated: August 17, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Disto Pharmaceuticals Private Limited is a company based in India, with its head office in Rangareddy. It operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on May 09, 2002. The total number of employees is currently 122 (2026). The company’s latest financial report indicates a net sales revenue increase of 37.22% in 2025. Its’ total assets recorded a growth of 36.78%. Disto Pharmaceuticals Private Limited’s net profit margin increased by 16.38% in 2025.

Headquarters
Plot No. 22 Phase-I Cherlapally Industrial Area Hyderabad In-Ts In 500051
Rangareddy; Andhra Pradesh; Postal Code: 500051

Contact Details: Purchase the Disto Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Disto Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Disto Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Disto Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
May 09, 2002
Key Executives
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Disto Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
37.22%
Total Operating Revenue
37.85%
Operating Profit
419.61%
EBITDA
231.51%
Net Profit/Loss for the Period
4936.02%
Total Assets
36.78%
Total Equity
41.87%
Operating Profit Margin
18.49%
Net Profit Margin
16.38%
Return on Equity (ROE)
28.68%
Debt / Equity
-6.52%
Quick Ratio
0.69%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?